[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Fibrin Degradation Product (FnDP) Assays Market - Global Outlook and Forecast 2021-2027

April 2021 | 93 pages | ID: F49176A1085AEN
Market Monitor Global

US$ 3,250.00

E-mail Delivery (PDF)

Download PDF Leaflet

Wire Transfer
Checkout Later
Need Help? Ask a Question
This report contains market size and forecasts of Fibrin Degradation Product (FnDP) Assays in Global, including the following market information:

Global Fibrin Degradation Product (FnDP) Assays Market Revenue, 2016-2021, 2022-2027, ($ millions)

Global top five companies in 2020 (%)

The global Fibrin Degradation Product (FnDP) Assays market was valued at xx million in 2020 and is projected to reach US$ xx million by 2027, at a CAGR of xx% during the forecast period.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Fibrin Degradation Product (FnDP) Assays companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Fibrin Degradation Product (FnDP) Assays Market, By Type, 2016-2021, 2022-2027 ($ millions)

Global Fibrin Degradation Product (FnDP) Assays Market Segment Percentages, By Type, 2020 (%)
  • Plasma
  • Serum
China Fibrin Degradation Product (FnDP) Assays Market, By Application, 2016-2021, 2022-2027 ($ millions)

China Fibrin Degradation Product (FnDP) Assays Market Segment Percentages, By Application, 2020 (%)
  • Hospital
  • Specialty Clinics
  • Diagnostic Laboratory
  • Others
Global Fibrin Degradation Product (FnDP) Assays Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions)

Global Fibrin Degradation Product (FnDP) Assays Market Segment Percentages, By Region and Country, 2020 (%)
  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Russia
    • Nordic Countries
    • Benelux
    • Rest of Europe
  • Asia
    • China
    • Japan
    • South Korea
    • Southeast Asia
    • India
    • Rest of Asia
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Middle East & Africa
    • Turkey
    • Israel
    • Saudi Arabia
    • UAE
    • Rest of Middle East & Africa
Competitor Analysis

The report also provides analysis of leading market participants including:

Total Fibrin Degradation Product (FnDP) Assays Market Competitors Revenues in Global, by Players 2016-2021 (Estimated), ($ millions)

Total Fibrin Degradation Product (FnDP) Assays Market Competitors Revenues Share in Global, by Players 2020 (%)

Further, the report presents profiles of competitors in the market, including the following:
  • Sekisui Diagnostics (Sekisui Chemical)
  • Randox Laboratories
  • Beckman Coulter Inc. (Danaher Corporation)
  • Kamiya Biomedical Company
  • ADALTIS S.r.l.
  • SDIX, LLC
  • Lab Mark A.s.
  • Abbott Laboratories
  • IBL International (Tecan Group Ltd.)
  • Analytik Jena AG
1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Fibrin Degradation Product (FnDP) Assays Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Fibrin Degradation Product (FnDP) Assays Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL FIBRIN DEGRADATION PRODUCT (FNDP) ASSAYS OVERALL MARKET SIZE

2.1 Global Fibrin Degradation Product (FnDP) Assays Market Size: 2021 VS 2027
2.2 Global Fibrin Degradation Product (FnDP) Assays Market Size, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Fibrin Degradation Product (FnDP) Assays Players in Global Market
3.2 Top Global Fibrin Degradation Product (FnDP) Assays Companies Ranked by Revenue
3.3 Global Fibrin Degradation Product (FnDP) Assays Revenue by Companies
3.4 Top 3 and Top 5 Fibrin Degradation Product (FnDP) Assays Companies in Global Market, by Revenue in 2020
3.5 Global Companies Fibrin Degradation Product (FnDP) Assays Product Type
3.6 Tier 1, Tier 2 and Tier 3 Fibrin Degradation Product (FnDP) Assays Players in Global Market
  3.6.1 List of Global Tier 1 Fibrin Degradation Product (FnDP) Assays Companies
  3.6.2 List of Global Tier 2 and Tier 3 Fibrin Degradation Product (FnDP) Assays Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 By Type - Global Fibrin Degradation Product (FnDP) Assays Market Size Markets, 2021 & 2027
  4.1.2 Plasma
  4.1.3 Serum
4.2 By Type - Global Fibrin Degradation Product (FnDP) Assays Revenue & Forecasts
  4.2.1 By Type - Global Fibrin Degradation Product (FnDP) Assays Revenue, 2016-2021
  4.2.2 By Type - Global Fibrin Degradation Product (FnDP) Assays Revenue, 2022-2027
  4.2.3 By Type - Global Fibrin Degradation Product (FnDP) Assays Revenue Market Share, 2016-2027

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Fibrin Degradation Product (FnDP) Assays Market Size, 2021 & 2027
  5.1.2 Hospital
  5.1.3 Specialty Clinics
  5.1.4 Diagnostic Laboratory
  5.1.5 Others
5.2 By Application - Global Fibrin Degradation Product (FnDP) Assays Revenue & Forecasts
  5.2.1 By Application - Global Fibrin Degradation Product (FnDP) Assays Revenue, 2016-2021
  5.2.2 By Application - Global Fibrin Degradation Product (FnDP) Assays Revenue, 2022-2027
  5.2.3 By Application - Global Fibrin Degradation Product (FnDP) Assays Revenue Market Share, 2016-2027

6 SIGHTS BY REGION

6.1 By Region - Global Fibrin Degradation Product (FnDP) Assays Market Size, 2021 & 2027
6.2 By Region - Global Fibrin Degradation Product (FnDP) Assays Revenue & Forecasts
  6.2.1 By Region - Global Fibrin Degradation Product (FnDP) Assays Revenue, 2016-2021
  6.2.2 By Region - Global Fibrin Degradation Product (FnDP) Assays Revenue, 2022-2027
  6.2.3 By Region - Global Fibrin Degradation Product (FnDP) Assays Revenue Market Share, 2016-2027
6.3 North America
  6.3.1 By Country - North America Fibrin Degradation Product (FnDP) Assays Revenue, 2016-2027
  6.3.2 US Fibrin Degradation Product (FnDP) Assays Market Size, 2016-2027
  6.3.3 Canada Fibrin Degradation Product (FnDP) Assays Market Size, 2016-2027
  6.3.4 Mexico Fibrin Degradation Product (FnDP) Assays Market Size, 2016-2027
6.4 Europe
  6.4.1 By Country - Europe Fibrin Degradation Product (FnDP) Assays Revenue, 2016-2027
  6.4.2 Germany Fibrin Degradation Product (FnDP) Assays Market Size, 2016-2027
  6.4.3 France Fibrin Degradation Product (FnDP) Assays Market Size, 2016-2027
  6.4.4 U.K. Fibrin Degradation Product (FnDP) Assays Market Size, 2016-2027
  6.4.5 Italy Fibrin Degradation Product (FnDP) Assays Market Size, 2016-2027
  6.4.6 Russia Fibrin Degradation Product (FnDP) Assays Market Size, 2016-2027
  6.4.7 Nordic Countries Fibrin Degradation Product (FnDP) Assays Market Size, 2016-2027
  6.4.8 Benelux Fibrin Degradation Product (FnDP) Assays Market Size, 2016-2027
6.5 Asia
  6.5.1 By Region - Asia Fibrin Degradation Product (FnDP) Assays Revenue, 2016-2027
  6.5.2 China Fibrin Degradation Product (FnDP) Assays Market Size, 2016-2027
  6.5.3 Japan Fibrin Degradation Product (FnDP) Assays Market Size, 2016-2027
  6.5.4 South Korea Fibrin Degradation Product (FnDP) Assays Market Size, 2016-2027
  6.5.5 Southeast Asia Fibrin Degradation Product (FnDP) Assays Market Size, 2016-2027
  6.5.6 India Fibrin Degradation Product (FnDP) Assays Market Size, 2016-2027
6.6 South America
  6.6.1 By Country - South America Fibrin Degradation Product (FnDP) Assays Revenue, 2016-2027
  6.6.2 Brazil Fibrin Degradation Product (FnDP) Assays Market Size, 2016-2027
  6.6.3 Argentina Fibrin Degradation Product (FnDP) Assays Market Size, 2016-2027
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Fibrin Degradation Product (FnDP) Assays Revenue, 2016-2027
  6.7.2 Turkey Fibrin Degradation Product (FnDP) Assays Market Size, 2016-2027
  6.7.3 Israel Fibrin Degradation Product (FnDP) Assays Market Size, 2016-2027
  6.7.4 Saudi Arabia Fibrin Degradation Product (FnDP) Assays Market Size, 2016-2027
  6.7.5 UAE Fibrin Degradation Product (FnDP) Assays Market Size, 2016-2027

7 PLAYERS PROFILES

7.1 Sekisui Diagnostics (Sekisui Chemical)
  7.1.1 Sekisui Diagnostics (Sekisui Chemical) Corporate Summary
  7.1.2 Sekisui Diagnostics (Sekisui Chemical) Business Overview
  7.1.3 Sekisui Diagnostics (Sekisui Chemical) Fibrin Degradation Product (FnDP) Assays Major Product Offerings
  7.1.4 Sekisui Diagnostics (Sekisui Chemical) Fibrin Degradation Product (FnDP) Assays Revenue in Global (2016-2021)
  7.1.5 Sekisui Diagnostics (Sekisui Chemical) Key News
7.2 Randox Laboratories
  7.2.1 Randox Laboratories Corporate Summary
  7.2.2 Randox Laboratories Business Overview
  7.2.3 Randox Laboratories Fibrin Degradation Product (FnDP) Assays Major Product Offerings
  7.2.4 Randox Laboratories Fibrin Degradation Product (FnDP) Assays Revenue in Global (2016-2021)
  7.2.5 Randox Laboratories Key News
7.3 Beckman Coulter Inc. (Danaher Corporation)
  7.3.1 Beckman Coulter Inc. (Danaher Corporation) Corporate Summary
  7.3.2 Beckman Coulter Inc. (Danaher Corporation) Business Overview
  7.3.3 Beckman Coulter Inc. (Danaher Corporation) Fibrin Degradation Product (FnDP) Assays Major Product Offerings
  7.3.4 Beckman Coulter Inc. (Danaher Corporation) Fibrin Degradation Product (FnDP) Assays Revenue in Global (2016-2021)
  7.3.5 Beckman Coulter Inc. (Danaher Corporation) Key News
7.4 Kamiya Biomedical Company
  7.4.1 Kamiya Biomedical Company Corporate Summary
  7.4.2 Kamiya Biomedical Company Business Overview
  7.4.3 Kamiya Biomedical Company Fibrin Degradation Product (FnDP) Assays Major Product Offerings
  7.4.4 Kamiya Biomedical Company Fibrin Degradation Product (FnDP) Assays Revenue in Global (2016-2021)
  7.4.5 Kamiya Biomedical Company Key News
7.5 ADALTIS S.r.l.
  7.5.1 ADALTIS S.r.l. Corporate Summary
  7.5.2 ADALTIS S.r.l. Business Overview
  7.5.3 ADALTIS S.r.l. Fibrin Degradation Product (FnDP) Assays Major Product Offerings
  7.5.4 ADALTIS S.r.l. Fibrin Degradation Product (FnDP) Assays Revenue in Global (2016-2021)
  7.5.5 ADALTIS S.r.l. Key News
7.6 SDIX, LLC
  7.6.1 SDIX, LLC Corporate Summary
  7.6.2 SDIX, LLC Business Overview
  7.6.3 SDIX, LLC Fibrin Degradation Product (FnDP) Assays Major Product Offerings
  7.6.4 SDIX, LLC Fibrin Degradation Product (FnDP) Assays Revenue in Global (2016-2021)
  7.6.5 SDIX, LLC Key News
7.7 Lab Mark A.s.
  7.7.1 Lab Mark A.s. Corporate Summary
  7.7.2 Lab Mark A.s. Business Overview
  7.7.3 Lab Mark A.s. Fibrin Degradation Product (FnDP) Assays Major Product Offerings
  7.4.4 Lab Mark A.s. Fibrin Degradation Product (FnDP) Assays Revenue in Global (2016-2021)
  7.7.5 Lab Mark A.s. Key News
7.8 Abbott Laboratories
  7.8.1 Abbott Laboratories Corporate Summary
  7.8.2 Abbott Laboratories Business Overview
  7.8.3 Abbott Laboratories Fibrin Degradation Product (FnDP) Assays Major Product Offerings
  7.8.4 Abbott Laboratories Fibrin Degradation Product (FnDP) Assays Revenue in Global (2016-2021)
  7.8.5 Abbott Laboratories Key News
7.9 IBL International (Tecan Group Ltd.)
  7.9.1 IBL International (Tecan Group Ltd.) Corporate Summary
  7.9.2 IBL International (Tecan Group Ltd.) Business Overview
  7.9.3 IBL International (Tecan Group Ltd.) Fibrin Degradation Product (FnDP) Assays Major Product Offerings
  7.9.4 IBL International (Tecan Group Ltd.) Fibrin Degradation Product (FnDP) Assays Revenue in Global (2016-2021)
  7.9.5 IBL International (Tecan Group Ltd.) Key News
7.10 Analytik Jena AG
  7.10.1 Analytik Jena AG Corporate Summary
  7.10.2 Analytik Jena AG Business Overview
  7.10.3 Analytik Jena AG Fibrin Degradation Product (FnDP) Assays Major Product Offerings
  7.10.4 Analytik Jena AG Fibrin Degradation Product (FnDP) Assays Revenue in Global (2016-2021)
  7.10.5 Analytik Jena AG Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES

Table 1. Fibrin Degradation Product (FnDP) Assays Market Opportunities & Trends in Global Market
Table 2. Fibrin Degradation Product (FnDP) Assays Market Drivers in Global Market
Table 3. Fibrin Degradation Product (FnDP) Assays Market Restraints in Global Market
Table 4. Key Players of Fibrin Degradation Product (FnDP) Assays in Global Market
Table 5. Top Fibrin Degradation Product (FnDP) Assays Players in Global Market, Ranking by Revenue (2019)
Table 6. Global Fibrin Degradation Product (FnDP) Assays Revenue by Companies, (US$, Mn), 2016-2021
Table 7. Global Fibrin Degradation Product (FnDP) Assays Revenue Share by Companies, 2016-2021
Table 8. Global Companies Fibrin Degradation Product (FnDP) Assays Product Type
Table 9. List of Global Tier 1 Fibrin Degradation Product (FnDP) Assays Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Fibrin Degradation Product (FnDP) Assays Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type – Global Fibrin Degradation Product (FnDP) Assays Revenue, (US$, Mn), 2021 VS 2027
Table 12. By Type - Fibrin Degradation Product (FnDP) Assays Revenue in Global (US$, Mn), 2016-2021
Table 13. By Type - Fibrin Degradation Product (FnDP) Assays Revenue in Global (US$, Mn), 2022-2027
Table 14. By Application – Global Fibrin Degradation Product (FnDP) Assays Revenue, (US$, Mn), 2021 VS 2027
Table 15. By Application - Fibrin Degradation Product (FnDP) Assays Revenue in Global (US$, Mn), 2016-2021
Table 16. By Application - Fibrin Degradation Product (FnDP) Assays Revenue in Global (US$, Mn), 2022-2027
Table 17. By Region – Global Fibrin Degradation Product (FnDP) Assays Revenue, (US$, Mn), 2021 VS 2027
Table 18. By Region - Global Fibrin Degradation Product (FnDP) Assays Revenue (US$, Mn), 2016-2021
Table 19. By Region - Global Fibrin Degradation Product (FnDP) Assays Revenue (US$, Mn), 2022-2027
Table 20. By Country - North America Fibrin Degradation Product (FnDP) Assays Revenue, (US$, Mn), 2016-2021
Table 21. By Country - North America Fibrin Degradation Product (FnDP) Assays Revenue, (US$, Mn), 2022-2027
Table 22. By Country - Europe Fibrin Degradation Product (FnDP) Assays Revenue, (US$, Mn), 2016-2021
Table 23. By Country - Europe Fibrin Degradation Product (FnDP) Assays Revenue, (US$, Mn), 2022-2027
Table 24. By Region - Asia Fibrin Degradation Product (FnDP) Assays Revenue, (US$, Mn), 2016-2021
Table 25. By Region - Asia Fibrin Degradation Product (FnDP) Assays Revenue, (US$, Mn), 2022-2027
Table 26. By Country - South America Fibrin Degradation Product (FnDP) Assays Revenue, (US$, Mn), 2016-2021
Table 27. By Country - South America Fibrin Degradation Product (FnDP) Assays Revenue, (US$, Mn), 2022-2027
Table 28. By Country - Middle East & Africa Fibrin Degradation Product (FnDP) Assays Revenue, (US$, Mn), 2016-2021
Table 29. By Country - Middle East & Africa Fibrin Degradation Product (FnDP) Assays Revenue, (US$, Mn), 2022-2027
Table 30. Sekisui Diagnostics (Sekisui Chemical) Corporate Summary
Table 31. Sekisui Diagnostics (Sekisui Chemical) Fibrin Degradation Product (FnDP) Assays Product Offerings
Table 32. Sekisui Diagnostics (Sekisui Chemical) Fibrin Degradation Product (FnDP) Assays Revenue (US$, Mn), (2016-2021)
Table 33. Randox Laboratories Corporate Summary
Table 34. Randox Laboratories Fibrin Degradation Product (FnDP) Assays Product Offerings
Table 35. Randox Laboratories Fibrin Degradation Product (FnDP) Assays Revenue (US$, Mn), (2016-2021)
Table 36. Beckman Coulter Inc. (Danaher Corporation) Corporate Summary
Table 37. Beckman Coulter Inc. (Danaher Corporation) Fibrin Degradation Product (FnDP) Assays Product Offerings
Table 38. Beckman Coulter Inc. (Danaher Corporation) Fibrin Degradation Product (FnDP) Assays Revenue (US$, Mn), (2016-2021)
Table 39. Kamiya Biomedical Company Corporate Summary
Table 40. Kamiya Biomedical Company Fibrin Degradation Product (FnDP) Assays Product Offerings
Table 41. Kamiya Biomedical Company Fibrin Degradation Product (FnDP) Assays Revenue (US$, Mn), (2016-2021)
Table 42. ADALTIS S.r.l. Corporate Summary
Table 43. ADALTIS S.r.l. Fibrin Degradation Product (FnDP) Assays Product Offerings
Table 44. ADALTIS S.r.l. Fibrin Degradation Product (FnDP) Assays Revenue (US$, Mn), (2016-2021)
Table 45. SDIX, LLC Corporate Summary
Table 46. SDIX, LLC Fibrin Degradation Product (FnDP) Assays Product Offerings
Table 47. SDIX, LLC Fibrin Degradation Product (FnDP) Assays Revenue (US$, Mn), (2016-2021)
Table 48. Lab Mark A.s. Corporate Summary
Table 49. Lab Mark A.s. Fibrin Degradation Product (FnDP) Assays Product Offerings
Table 50. Lab Mark A.s. Fibrin Degradation Product (FnDP) Assays Revenue (US$, Mn), (2016-2021)
Table 51. Abbott Laboratories Corporate Summary
Table 52. Abbott Laboratories Fibrin Degradation Product (FnDP) Assays Product Offerings
Table 53. Abbott Laboratories Fibrin Degradation Product (FnDP) Assays Revenue (US$, Mn), (2016-2021)
Table 54. IBL International (Tecan Group Ltd.) Corporate Summary
Table 55. IBL International (Tecan Group Ltd.) Fibrin Degradation Product (FnDP) Assays Product Offerings
Table 56. IBL International (Tecan Group Ltd.) Fibrin Degradation Product (FnDP) Assays Revenue (US$, Mn), (2016-2021)
Table 57. Analytik Jena AG Corporate Summary
Table 58. Analytik Jena AG Fibrin Degradation Product (FnDP) Assays Product Offerings
Table 59. Analytik Jena AG Fibrin Degradation Product (FnDP) Assays Revenue (US$, Mn), (2016-2021)

LIST OF FIGURES

Figure 1. Fibrin Degradation Product (FnDP) Assays Segment by Type
Figure 2. Fibrin Degradation Product (FnDP) Assays Segment by Application
Figure 3. Global Fibrin Degradation Product (FnDP) Assays Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global Fibrin Degradation Product (FnDP) Assays Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. Global Fibrin Degradation Product (FnDP) Assays Revenue, 2016-2027 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Fibrin Degradation Product (FnDP) Assays Revenue in 2020
Figure 8. By Type - Global Fibrin Degradation Product (FnDP) Assays Revenue Market Share, 2016-2027
Figure 9. By Application - Global Fibrin Degradation Product (FnDP) Assays Revenue Market Share, 2016-2027
Figure 10. By Region - Global Fibrin Degradation Product (FnDP) Assays Revenue Market Share, 2016-2027
Figure 11. By Country - North America Fibrin Degradation Product (FnDP) Assays Revenue Market Share, 2016-2027
Figure 12. US Fibrin Degradation Product (FnDP) Assays Revenue, (US$, Mn), 2016-2027
Figure 13. Canada Fibrin Degradation Product (FnDP) Assays Revenue, (US$, Mn), 2016-2027
Figure 14. Mexico Fibrin Degradation Product (FnDP) Assays Revenue, (US$, Mn), 2016-2027
Figure 15. By Country - Europe Fibrin Degradation Product (FnDP) Assays Revenue Market Share, 2016-2027
Figure 16. Germany Fibrin Degradation Product (FnDP) Assays Revenue, (US$, Mn), 2016-2027
Figure 17. France Fibrin Degradation Product (FnDP) Assays Revenue, (US$, Mn), 2016-2027
Figure 18. U.K. Fibrin Degradation Product (FnDP) Assays Revenue, (US$, Mn), 2016-2027
Figure 19. Italy Fibrin Degradation Product (FnDP) Assays Revenue, (US$, Mn), 2016-2027
Figure 20. Russia Fibrin Degradation Product (FnDP) Assays Revenue, (US$, Mn), 2016-2027
Figure 21. Nordic Countries Fibrin Degradation Product (FnDP) Assays Revenue, (US$, Mn), 2016-2027
Figure 22. Benelux Fibrin Degradation Product (FnDP) Assays Revenue, (US$, Mn), 2016-2027
Figure 23. By Region - Asia Fibrin Degradation Product (FnDP) Assays Revenue Market Share, 2016-2027
Figure 24. China Fibrin Degradation Product (FnDP) Assays Revenue, (US$, Mn), 2016-2027
Figure 25. Japan Fibrin Degradation Product (FnDP) Assays Revenue, (US$, Mn), 2016-2027
Figure 26. South Korea Fibrin Degradation Product (FnDP) Assays Revenue, (US$, Mn), 2016-2027
Figure 27. Southeast Asia Fibrin Degradation Product (FnDP) Assays Revenue, (US$, Mn), 2016-2027
Figure 28. India Fibrin Degradation Product (FnDP) Assays Revenue, (US$, Mn), 2016-2027
Figure 29. By Country - South America Fibrin Degradation Product (FnDP) Assays Revenue Market Share, 2016-2027
Figure 30. Brazil Fibrin Degradation Product (FnDP) Assays Revenue, (US$, Mn), 2016-2027
Figure 31. Argentina Fibrin Degradation Product (FnDP) Assays Revenue, (US$, Mn), 2016-2027
Figure 32. By Country - Middle East & Africa Fibrin Degradation Product (FnDP) Assays Revenue Market Share, 2016-2027
Figure 33. Turkey Fibrin Degradation Product (FnDP) Assays Revenue, (US$, Mn), 2016-2027
Figure 34. Israel Fibrin Degradation Product (FnDP) Assays Revenue, (US$, Mn), 2016-2027
Figure 35. Saudi Arabia Fibrin Degradation Product (FnDP) Assays Revenue, (US$, Mn), 2016-2027
Figure 36. UAE Fibrin Degradation Product (FnDP) Assays Revenue, (US$, Mn), 2016-2027
Figure 37. Sekisui Diagnostics (Sekisui Chemical) Fibrin Degradation Product (FnDP) Assays Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 38. Randox Laboratories Fibrin Degradation Product (FnDP) Assays Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 39. Beckman Coulter Inc. (Danaher Corporation) Fibrin Degradation Product (FnDP) Assays Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 40. Kamiya Biomedical Company Fibrin Degradation Product (FnDP) Assays Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 41. ADALTIS S.r.l. Fibrin Degradation Product (FnDP) Assays Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 42. SDIX, LLC Fibrin Degradation Product (FnDP) Assays Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 43. Lab Mark A.s. Fibrin Degradation Product (FnDP) Assays Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 44. Abbott Laboratories Fibrin Degradation Product (FnDP) Assays Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 45. IBL International (Tecan Group Ltd.) Fibrin Degradation Product (FnDP) Assays Revenue Year Over Year Growth (US$, Mn) & (2016-2021)


More Publications